par Robberecht, Patrick 
;Tatemoto, Kazuhiko;Chatelain, Pierre ;Waelbroeck, Magali ;Delhaye, Myriam ;Taton, Gérard ;De Neef, Philippe ;Camus, Jean Claude ;Heuse, Danielle;Christophe, Jean
Référence Regulatory peptides, 4, 5, page (241-250)
Publication Publié, 1982-10
;Tatemoto, Kazuhiko;Chatelain, Pierre ;Waelbroeck, Magali ;Delhaye, Myriam ;Taton, Gérard ;De Neef, Philippe ;Camus, Jean Claude ;Heuse, Danielle;Christophe, Jean Référence Regulatory peptides, 4, 5, page (241-250)
Publication Publié, 1982-10
Article révisé par les pairs
| Résumé : | The presence of receptors, recognized by vasoactive intestinal peptide (VIP) as well as by PHI (a peptide with N-terminal histidine and C-terminal isoleucine amide), was documented in lung membranes from rat, mouse, guinea pig and man by the ability of these receptors, once occupied, to stimulate adenylate cyclase. In lung membranes from rat, mouse and guinea pig, the capacity of VIP, PHI and secretin to stimulate the enzyme and the potency of the same peptides to compete with 125I-VIP for binding to VIP receptors were similar, the affinity decreasing in the order: VIP greater than PHI greater than secretin. In addition, dose-effect curves were compatible with the coexistence of high-affinity and low-affinity VIP receptors, in the four animal species considered. If PHI was able to recognize all VIP receptors it could not, however, discriminate the subclasses of VIP receptors. |
